Print this page
-
A Phase 1 Study to Assess the Safety and Efficacy of LYL845 in Adults with Relapsed and/or Refractory Metastatic or Locally Advanced Melanoma and Selected Solid Tumor Malignancies.
Protocol: 092205Principal Investigator:
- Sarah Weiss MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Melanoma, Skin -
Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma.
Protocol: 092202Principal Investigator:
- Adam Berger (Rutgers University)
Applicable Disease Sites: Melanoma, Skin -
A Digital Intervention to Improve Skin Self-Examination Among Melanoma Survivors.
Protocol: 132202Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Melanoma, Skin -
A Multi-Level Investigation of US Indoor Tanning Policy Enactment, Implementation, Compliance, Impact, and Economics.
Protocol: 132005Principal Investigator:
- Carolyn Heckman Ph.D. (Rutgers University)
Applicable Disease Sites: Melanoma, Skin -
Facebook Intervention for Young Onset Melanoma Patients and Families.
Protocol: 131812Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Melanoma, Skin -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
- Deborah Toppmeyer M.D. (Rutgers University)
Applicable Disease Sites: Pancreas
Melanoma, Skin
Colon
Ovary
Soft Tissue
Prostate
Kidney
Breast
- 1
- 2